{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:33:21Z","timestamp":1779370401564,"version":"3.53.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tehran University of Medical Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.pharep.2018.12.012","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T12:05:56Z","timestamp":1545998756000},"page":"282-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Role of vitamin D and vitamin D receptor gene polymorphisms on residual beta cell function in children with type 1 diabetes mellitus"],"prefix":"10.1007","volume":"71","author":[{"given":"Narges","family":"Habibian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa M.","family":"Amoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Alipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sayarifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9691-7558","authenticated-orcid":false,"given":"Parastoo","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh Parichehreh","family":"Dizaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Saadati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aria","family":"Setoodeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2013","key":"10.1016\/j.pharep.2018.12.012_bib0005","first-page":"148673","article-title":"The role of vitamin d deficiency in the incidence, progression, and complications of type 1 diabetes mellitus","author":"Chakhtoura","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.pharep.2018.12.012_bib0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/14737159.2016.1210513","article-title":"The clinical potential of low-level C-peptide secretion","volume":"16","author":"Ludvigsson","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.pharep.2018.12.012_bib0015","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.clnu.2013.01.012","article-title":"A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes","volume":"32","author":"Ataie-Jafari","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.pharep.2018.12.012_bib0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1515\/jpem-2015-0088","article-title":"Effect of 6-months\u2019 vitamin D supplementation on residual beta cell function in children with type 1 diabetes: a case control interventional study","volume":"29","author":"Mishra","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.pharep.2018.12.012_bib0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archpediatrics.2012.164","article-title":"Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual \u03b2-cell function in new-onset type 1 diabetes mellitus","volume":"166","author":"Gabbay","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.pharep.2018.12.012_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/genes8040125","article-title":"Inherited variation in vitamin D genes and type 1 diabetes predisposition","volume":"8","author":"Penna-Martinez","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.pharep.2018.12.012_bib0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2265.2000.00985.x","article-title":"Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population","volume":"52","author":"Chang","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharep.2018.12.012_bib0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humimm.2008.01.008","article-title":"Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population","volume":"69","author":"Lemos","year":"2008","journal-title":"Hum Immunol"},{"key":"10.1016\/j.pharep.2018.12.012_bib0045","article-title":"Serum vitamin D levels and gene polymorphisms (Fok1 and Apa1) in children with type I diabetes and healthy controls","volume":"66","author":"Nasreen","year":"2016","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.pharep.2018.12.012_bib0050","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s11033-011-0805-3","article-title":"Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population","volume":"39","author":"Mohammadnejad","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.pharep.2018.12.012_bib0055","doi-asserted-by":"crossref","first-page":"614","DOI":"10.26719\/2012.18.6.614","volume":"18","author":"Bonakdaran","year":"2012","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.pharep.2018.12.012_bib0060","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1055\/s-2002-33262","article-title":"VDR gene polymorphisms are overrepresented in German patients with type 1 diabetes compared to healthy controls without effect on biochemical parameters of bone metabolism","volume":"34","author":"Fassbender","year":"2002","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pharep.2018.12.012_bib0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.clim.2009.08.004","article-title":"Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece","volume":"133","author":"Panierakis","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.pharep.2018.12.012_bib0070","doi-asserted-by":"crossref","first-page":"e89325","DOI":"10.1371\/journal.pone.0089325","article-title":"Associations between two polymorphisms (FokI and BsmI) of vitamin D receptor gene and type 1 diabetes mellitus in Asian population: a meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2018.12.012_bib0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/EC-16-0110","article-title":"Association of vitamin D receptor polymorphisms and type 1 diabetes susceptibility in children: a meta-analysis","volume":"6","author":"Sahin","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.pharep.2018.12.012_bib0080","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22397","article-title":"Evaluation of vitamin D receptor gene polymorphisms (Fok\u2010I and Bsm\u2010I) in T1DM Saudi children","author":"Ali","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.pharep.2018.12.012_bib0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jsbmb.2014.03.011","article-title":"Contribution of VDR polymorphisms to type 1 diabetes susceptibility: systematic review of case-control studies and meta-analysis","volume":"143","author":"Tizaoui","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pharep.2018.12.012_bib0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.clim.2015.08.002","article-title":"Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus\u2014a randomized clinical trial","volume":"161","author":"Treiber","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.pharep.2018.12.012_bib0095","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.2337\/dc10-0814","article-title":"No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial","volume":"33","author":"Bizzarri","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharep.2018.12.012_bib0100","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1464-5491.2006.01921.x","article-title":"The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI)","volume":"23","author":"Pitocco","year":"2006","journal-title":"Diabet Med"},{"issue":"15","key":"10.1016\/j.pharep.2018.12.012_bib0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/pedi.12186","article-title":"ISPAD Clinical Practice Consensus Guidelines 2014. Definition, epidemiology, and classification of diabetes in children and adolescents","author":"Craig","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.pharep.2018.12.012_bib0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/pedi.12165","article-title":"Diabetic ketoacidosis and hyperglycemic hyperosmolar state","volume":"15","author":"Wolfsdorf","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.pharep.2018.12.012_bib0115","series-title":"Synthesis and biologic activity of vitamin D. Pediatric endocrinology","first-page":"231","author":"Sperling","year":"2014"},{"key":"10.1016\/j.pharep.2018.12.012_bib0120","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2865","article-title":"T-lymphocyte and glycemic status after vitamin D treatment in type 1 diabetes: a randomized controlled trial with sequential crossover","volume":"33","author":"Bogdanou","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.pharep.2018.12.012_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178695","article-title":"The associations between VDR BsmI polymorphisms and risk of vitamin D deficiency, obesity and insulin resistance in adolescents residing in a tropical country","volume":"12","author":"Rahmadhani","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2018.12.012_bib0130","article-title":"Plasma 25-hydroxyvitamin D concentration and risk of islet autoimmunity","author":"Norris","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.pharep.2018.12.012_bib0135","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/dmrr.977","article-title":"Protective effects of 1\u2010\u03b1\u2010hydroxyvitamin D3 on residual \u03b2\u2010cell function in patients with adult\u2010onset latent autoimmune diabetes (LADA)","volume":"25","author":"Li","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.pharep.2018.12.012_bib0140","article-title":"Preservation of residual beta cell function with vitamin D supplementation in type 1 diabetes","volume":"2","author":"Dayal","year":"2015","journal-title":"Immunoendocrinology (Houst)"},{"key":"10.1016\/j.pharep.2018.12.012_bib0145","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/dc09-2297","article-title":"No effect of the 1alpha, 25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes","volume":"33","author":"Walter","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharep.2018.12.012_bib0150","first-page":"67","article-title":"Immune function of vitamin D in type 1 diabetes mellitus","volume":"4","author":"Li","year":"2014","journal-title":"IJBM"},{"key":"10.1016\/j.pharep.2018.12.012_bib0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1515\/jpem-2016-0292","article-title":"Vitamin D status in Egyptian children with type 1 diabetes and the role of vitamin D replacement in glycemic control","volume":"30","author":"Hafez","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.pharep.2018.12.012_bib0160","first-page":"377","article-title":"Vitamin D status of 6-to 7-year-old children living in Isfahan, Iran","volume":"61","author":"Ardestani","year":"2010","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.pharep.2018.12.012_bib0165","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3109\/03014460903527348","article-title":"Assessment of vitamin D status in healthy children and adolescents living in Tehran and its relation to iPTH, gender, weight and height","volume":"37","author":"Razzaghy-Azar","year":"2010","journal-title":"Ann Hum Biol"},{"key":"10.1016\/j.pharep.2018.12.012_bib0170","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1017\/S1368980011000188","article-title":"High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a red alert","volume":"15","author":"Neyestani","year":"2012","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.pharep.2018.12.012_bib0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2251-6581-11-12","article-title":"Vitamin D status and associated factors in recent-onset type 1 diabetic children in Iran","volume":"11","author":"Ataie-Jafari","year":"2012","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.pharep.2018.12.012_bib0180","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1096\/fj.02-0424fje","article-title":"Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor","volume":"17","author":"Zeitz","year":"2003","journal-title":"Faseb J"},{"key":"10.1016\/j.pharep.2018.12.012_bib0185","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.humimm.2009.03.007","article-title":"Prevalence of vitamin D receptor gene polymorphisms FokI and BsmI in Brazilian individuals with type 1 diabetes and their relation to beta-cell autoimmunity and to remaining beta-cell function","volume":"70","author":"Mory","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.pharep.2018.12.012_bib0190","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1210\/jc.2004-2407","article-title":"Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes","volume":"90","author":"Taverna","year":"2005","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018303037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018303037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:51Z","timestamp":1752611871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.12.012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1734114018303037"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.12.012","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of vitamin D and vitamin D receptor gene polymorphisms on residual beta cell function in children with type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}